a:3:{s:6:"_token";s:40:"LLRpQMbnSbM6DUQScg2cnSsDnVox2olqC9BLbpSV";s:9:"_previous";a:1:{s:3:"url";s:143:"https://www.pharmafocusasia.com/news/medicenna-therapeutics-administers-initial-dose-in-phase-2-monotherapy-dose-expansion-component-of-ability";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}